Cytosorbents Corporation CTSO
5.81 USD 0.00 (+0.09%)
Nov 11, 2026, 2:01 PM EST
5.50 Day range 5.93
2.84 52-week range 17.00
- YTD
- -54.58%
- 1 year
- -58.42%
CTSO revenue history
Revenue is income from the company’s ordinary business activities.
37,063,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 37,063,000 | 1,468,000 | 4.12% |
| FY 2024 | 2024-12-31 | 35,595,000 | 4,510,047 | 14.51% |
| FY 2023 | 2023-12-31 | 31,084,953 | -3,603,856 | -10.39% |
| FY 2022 | 2022-12-31 | 34,688,809 | -8,476,718 | -19.64% |
| FY 2021 | 2021-12-31 | 43,165,527 | 2,160,926 | 5.27% |
| FY 2020 | 2020-12-31 | 41,004,601 | 16,055,128 | 64.35% |
| FY 2019 | 2019-12-31 | 24,949,473 | 2,445,565 | 10.87% |
| FY 2018 | 2018-12-31 | 22,503,908 | 7,353,154 | 48.53% |
| FY 2017 | 2017-12-31 | 15,150,754 | 5,622,911 | 59.02% |
| FY 2016 | 2016-12-31 | 9,527,843 | 4,736,227 | 98.84% |
| FY 2015 | 2015-12-31 | 4,791,616 | 668,791 | 16.22% |
| FY 2014 | 2014-12-31 | 4,122,825 | 1,700,158 | 70.18% |
| FY 2013 | 2013-12-31 | 2,422,667 | 1,079,731 | 80.40% |
| FY 2012 | 2012-12-31 | 1,342,936 | 1,306,858 | 3622.31% |
| FY 2011 | 2011-12-31 | 36,078 | 36,078 | Not meaningful |
| FY 2010 | 2010-12-31 | 0 | 0 | Not meaningful |
| FY 2009 | 2009-12-31 | 0 | 0 | Not meaningful |
| FY 2008 | 2008-12-31 | 0 | 0 | Not meaningful |
| FY 2007 | 2007-12-31 | 0 | 0 | Not meaningful |
| FY 2006 | 2006-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-09-11T06:02:17.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.